Türkiye Awards €34.05 Million Contract for Supply of Vaccines and Syringes Under SIHHAT III Project

Türkiye has strengthened its public health infrastructure through the award of a major healthcare procurement contract under the SIHHAT III Project. The contract, valued at €34.05 million, covers the supply of vaccines and syringes (injectors) to support immunization programs and healthcare services across the country.

The contract was awarded by the Republic of Türkiye Ministry of Health - General Directorate of Public Health on 6 March 2026 as part of ongoing efforts to enhance vaccine accessibility, strengthen disease prevention programs, and improve healthcare resilience.

The procurement forms a key component of Türkiye's commitment to maintaining robust public health systems and ensuring the availability of essential medical supplies.

Contract Overview

The contract was awarded under Reference Number SIHHAT/2025/SUP/INT/07 and includes the supply of vaccines and injection equipment necessary for national healthcare programs.

Key Contract Details

• Project: Supply of Vaccines and Syringes (Injectors)

• Contract Value: EUR 34,052,788

• Contract Date: 6 March 2026

• Reference Number: SIHHAT/2025/SUP/INT/07

• Contract Type: Supplies

• Purchaser: SIHHAT III Project, Republic of Türkiye Ministry of Health – General Directorate of Public Health

• Location: Ankara, Türkiye

• Notice Number: 163339-2026

• Published Date: 9 March 2026

Awarded Suppliers

The contract was awarded to a consortium of leading pharmaceutical and healthcare suppliers operating in Türkiye.

Selected Suppliers

• GlaxoSmithKline İlaçları Sanayi ve Ticaret A.Ş.

• Keymen İlaç Sanayi ve Ticaret A.Ş.

• Arvatera İlaç Sanayi ve Ticaret A.Ş.

• Pfizer PFE İlaçları A.Ş.

• Sıla Teknoloji ve Sağlık A.Ş.

These companies will contribute to the supply and distribution of vaccines and injection devices required under the project.

About the SIHHAT III Project

The SIHHAT Project is a major health sector initiative aimed at improving healthcare services, strengthening public health systems, and enhancing access to essential medical resources.

The program supports:

• Immunization and vaccination campaigns

• Healthcare service delivery improvements

• Public health preparedness

• Disease prevention initiatives

• Healthcare infrastructure strengthening

• Access to essential medicines and supplies

• Community health protection

Through strategic procurement activities, the project helps ensure the continuous availability of critical healthcare resources.

Importance of Vaccine Procurement

Vaccination remains one of the most effective public health interventions worldwide. Reliable access to vaccines and safe injection equipment is essential for protecting populations against infectious diseases and preventing outbreaks.

The procurement supports:

Disease Prevention

Vaccines help reduce the spread of infectious diseases and protect vulnerable populations.

Public Health Security

Adequate vaccine supplies strengthen national preparedness and response capabilities.

Healthcare System Resilience

Reliable medical supply chains improve the ability of healthcare systems to respond to health emergencies.

Community Protection

Expanded immunization coverage contributes to improved population health outcomes and reduced healthcare costs.

Scope of the Contract

The procurement includes the supply of vaccines and syringes used in immunization programs and healthcare facilities.

Main Components

• Vaccine supply and distribution

• Syringes and injection equipment

• Healthcare logistics support

• Immunization program resources

• Medical consumables for vaccination services

• Public health supply chain support

The supplies will support ongoing vaccination activities and contribute to maintaining high immunization coverage rates.

Economic and Healthcare Impact

The €34.05 million investment highlights Türkiye's continued commitment to strengthening healthcare services and protecting public health.

Expected Benefits

• Improved vaccine availability

• Enhanced immunization program capacity

• Increased healthcare preparedness

• Better disease prevention outcomes

• Strengthened healthcare supply chains

• Improved access to essential medical resources

Investments in preventive healthcare measures often generate substantial long-term economic and social benefits by reducing disease burdens and healthcare expenditures.

Strategic Importance for Türkiye

As healthcare systems continue to evolve in response to emerging health challenges, maintaining reliable access to vaccines and medical supplies remains a national priority.

The project supports:

• Sustainable healthcare development

• Public health modernization

• National immunization objectives

• Healthcare system strengthening

• Long-term health security planning

The procurement aligns with Türkiye's broader efforts to improve healthcare quality and resilience across the country.

Conclusion

The award of the €34.05 million contract for the supply of vaccines and syringes under the SIHHAT III Project represents a significant investment in public health and preventive healthcare. By securing essential medical supplies through partnerships with leading pharmaceutical and healthcare companies, Türkiye continues to strengthen its healthcare system and support national immunization programs.

As governments worldwide prioritize healthcare resilience and disease prevention, investments such as this play a crucial role in safeguarding public health and ensuring access to life-saving medical resources.

#Turkey tenders, #Türkiye healthcare project, #SIHHAT III Project, #vaccine procurement contract, #syringe supply tender, #Ministry of Health Turkey, #public health procurement, #immunization Turkey, #healthcare infrastructure development, #vaccine supply contract, #GlaxoSmithKline Turkey, #Pfizer Turkey, #medical supplies procurement, #government contracts Turkey, #healthcare tenders Europe, #public health investment, #vaccine distribution project